Showing results (201-210 of 248) with videos related to
Sort By:
Pageof 25
Surgical Innovation|June 30, 2016
Patient-Reported Convalescence and Quality of Life Recovery: A Comparison of Open and Robotic-Assisted Radical CystectomyAmy Y Li, Christopher P Filson, John M Hollingsworth, et al.JAMA|June 27, 2013
Use of advanced treatment technologies among men at low risk of dying from prostate cancerBruce L Jacobs, Yun Zhang, Florian R Schroeck, et al.The Journal of Urology|December 17, 2013
Satisfaction with information used to choose prostate cancer treatmentScott M Gilbert, Martin G Sanda, Rodney L Dunn, et al.European Urology|November 14, 2024
Epidemiology and Risk Factors for Testicular Cancer: A Systematic ReviewValentina Tateo, Zachary J Thompson, Scott M Gilbert, et al.Urologic Oncology|August 24, 2021
Comparative effectiveness analysis of first-line immunotherapy versus chemotherapy in metastatic urothelial carcinoma of the bladderNicholas H Chakiryan, Da David Jiang, Kyle A Gillis, et al.European Urology|October 6, 2023
Novel Use of Circulating Tumor DNA to Identify Muscle-invasive and Non-organ-confined Upper Tract Urothelial CarcinomaHeather L Huelster, Billie Gould, Elizabeth A Schiftan, et al.BJU International|July 18, 2019
Characterising 'bounce-back' readmissions after radical cystectomyPeter S Kirk, Ted A Skolarus, Bruce L Jacobs, et al.The Journal of Urology|August 5, 2025
Risk Factors for First-Year Recurrence in Patients With Synchronous Metastatic Renal Cell Carcinoma Undergoing Cytoreductive Nephrectomy and Complete MetastasectomyAli Ghasemzadeh, E Jason Abel, Jose A Karam, et al.World Journal of Urology|September 22, 2018
Update of the ICUD-SIU International Consultation on Bladder Cancer 2018: urinary diversionOscar Rodríguez Faba, Mark D Tyson, Walter Artibani, et al.JAMA Network Open|May 25, 2021
Real-World Survival Outcomes Associated With First-Line Immunotherapy, Targeted Therapy, and Combination Therapy for Metastatic Clear Cell Renal Cell CarcinomaNicholas H Chakiryan, Da David Jiang, Kyle A Gillis, et al.Pageof 25